TY  - JOUR
AU  - Cortés-Vicente, Elena
AU  - Rojas-Garcia, Ricard
AU  - Díaz-Manera, Jordi
AU  - Querol, Luis
AU  - Casasnovas, Carlos
AU  - Guerrero-Sola, Antonio
AU  - Muñoz-Blanco, José Luis
AU  - Bárcena-Llona, José Eulalio
AU  - Márquez-Infante, Celedonio
AU  - Pardo, Julio
AU  - Martínez-Fernández, Eva María
AU  - Usón, Mercedes
AU  - Oliva-Nacarino, Pedro
AU  - Sevilla, Teresa
AU  - Illa, Isabel
PY  - 2018
DO  - 10.1002/acn3.564
SN  - 2328-9503
UR  - http://hdl.handle.net/10668/12627
T2  - Annals of clinical and translational neurology
AB  - To evaluate whether the clinical benefit and relapse rates in anti-muscle-specific kinase (MuSK) myasthenia gravis (MG) differ depending on the protocol of rituximab followed. This retrospective multicentre study in patients with MuSK MG compared...
LA  - en
TI  - The impact of rituximab infusion protocol on the long-term outcome in anti-MuSK myasthenia gravis.
TY  - research article
VL  - 5
ER  -